Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19256 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) S - ATC / . DDD MON S01GX08 KETOTIFEN FUMARATE S01GX08 2879401 01 CLEROPTIC EY.DRO.SOL 0,025% W/V FLx5ML .. 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 2582901 01 DOVIDIN EY.DRO.SOL 0,025% (W/V) FLx5 ML 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 2686701 01 MENI-DROPS EY.DRO.SOL 0,025% W/V BTx1 FL x 5 ML .. 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 2573802 01 NOXTOR EY.DRO.SOL 0.025% FL X5ML RAFARM A.E.B.E. 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 1807305 01 ORPIDIX EY.DRO.SOL 0,025% W/V BTx 1 FL x 5 ML 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 2578001 01 URPEM EY.DR.S.SD 0,1mg/0,4ML BTX30X0,4ML SIN ZWITTER PHARM 2 15.000 0.7927 11.89 10.14 S01GX08 2578001 02 URPEM EY.DR.S.SD 0,1mg/0,4ML BTX20X0,4ML SIN ZWITTER PHARM 2 10.000 0.8380 8.38 6.76 S01GX08 1539905 01 ZADITEN EY.DRO.SOL 0,25MG/ML FLx5 ML LABORATOIRES T 0.5 ML 10.000 0.6570 6.57 6.57 S01GX08 1539906 02 ZADITEN EY.DRO.SOL 0,25MG/1 ML(SD BTx20(SDU x 0,4 LABORATOIRES T 2 10.000 0.8830 8.83 6.76 S01GX08 2576401 01 ZETHRINAL EY.DRO.SOL 0.00025 BTx1 VIALx5 ML CHEMICA PHARM 0.5 ML 10.000 0.5260 5.26 5.26 S01GX08 2576301 01 K-DROPS EY.DRO.SOL 0.00025 BTX1VIALX5ML - 0.5 ML 10.000 0.5260 5.26 5.26 S01GX09 OLOPATADINE HYDROCHLORIDE S01GX09 2527301 01 OPATANOL EY.DRO.SOL 1MG/ML FLX5ML ALCON LABORAT 0.5 ML 10.000 0.6080 6.08 6.08 S01GX10 EPINASTINE HYDROCHLORIDE S01GX10 2586301 01 RELESTAT EY.DRO.SOL 0,5MG/ML FLx5 ML ALLERGAN PHAR 0.5 ML 10.000 0.7130 7.13 6.76 S01H -T S01HA -T ( ) S01HA03 TETRACAINE HYDROCHLORIDE S01HA03 1910501 01 TETRACAINE HYDROCHLOEY.DRO.SOL 0.50% FLx10ML .. 0.5 ML 20.000 0.1535 3.07 3.07 S01HA04 PROXYMETACAINE HYDROCHLORIDE S01HA04 1915801 01 ALCAINE EY.DRO.SOL 0.5% BTX 1 BOTTLE X1 0.5 ML 30.000 0.0473 1.42 1.42 S01X S01XA - : " SJ ÖGREN" ( ) S01XA12 DEXPANTHENOL S01XA12 2243001 02 CORNEREGEL EYE.GEL 5% W/W BTX1(TUBX10G) KITE 0.5 G 20.000 0.1515 3.03 3.03 S01XA20 CARBOMER S01XA20 1971201 01 VISCOTER EYE.GEL 0.20% TUBx10G(. LABORATOIRES T 0.5 G 20.000 0.3050 6.10 4.93 S01XA20 CARBOMER 974P S01XA20 2592601 01 SICCAFLUID EYE.GEL 0.25% BTx1BOTTLEx10G LABORATOIRES T 0.5 G 20.000 0.1575 3.15 3.15
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19257 S - ATC / . DDD MON ( ) S01XA20 POLYVIDONE S01XA20 2325201 01 OCULOTECT EY.SOL.SD 20MG/0,4ML BTX20 LABORATOIRES T 4 TE 5.000 0.8740 4.37 3.74 S01XA20 POLYVIDONE 25 S01XA20 2351601 01 PROTAGENT EY.DRO.SOL 2.00% FLx10 ML .. 0.5 ML 20.000 0.1645 3.29 3.29 S01XA20 2351602 01 PROTAGENT EY.DR.S.SD 2.00% BTX20SDCX0.4M .. 4 TE 5.000 1.8720 9.36 3.74 S01XA20 POLYVINYL ALCOHOL,POLYVIDONE S01XA20 2460001 01 ONUFRID EY.DRO.SOL 1.4%+0.6% BTX1FL X12ML RAFARM A.E.B.E. 0.5 ML 24.000 0.0929 2.23 2.23 S02A - S02AA - ( ) S02AA15 CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE S02AA15 2589601 01 DROLL EA.SOL 1MG/0,5ML BTx20(S.D.x0,5ML GALENICA 2 TE 10.000 1.0970 10.97 10.97
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 297: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·